Genome Engineering as a Therapeutic Approach in Cancer Therapy: A Comprehensive Review
Abstract Cancer is one of the foremost causes of mortality. The human genome remains stable over time. However, human activities and environmental factors have the power to influence the prevalence of certain types of mutations. This goes to the excessive progress of xenobiotics and industrial devel...
Main Authors: | Jack Gemayel, Alain Chebly, Hampig Kourie, Colette Hanna, Kayane Mheidly, Melissa Mhanna, Farah Karam, Daniel Ghoussaini, Paula El Najjar, Charbel Khalil |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-03-01
|
Series: | Advanced Genetics |
Subjects: | |
Online Access: | https://doi.org/10.1002/ggn2.202300201 |
Similar Items
-
Allogeneic CAR-T Cells: More than Ease of Access?
by: Charlotte Graham, et al.
Published: (2018-10-01) -
In-Vivo Induced CAR-T Cell for the Potential Breakthrough to Overcome the Barriers of Current CAR-T Cell Therapy
by: Tianqing Xin, et al.
Published: (2022-02-01) -
Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing
by: Alexander Dimitri, et al.
Published: (2022-03-01) -
Exosome: A New Player in Translational Nanomedicine
by: Houssam Aheget, et al.
Published: (2020-07-01) -
CRISPR, CAR-T, and NK: Current applications and future perspectives
by: Mohadeseh Khoshandam, et al.
Published: (2024-07-01)